Known Uses Only (No New Predictions)

For these drugs, every candidate from the TxGNN model is already a known use (recorded in the knowledge graph or in a medicine licence), so there is no new predicted indication. Each page lists the known uses and the local market status.

52 drugs

Drug Report
Abemaciclib View page
Acetaminophen View page
Aluminum Hydroxide View page
Anidulafungin View page
Anifrolumab View page
Apraclonidine View page
Apremilast View page
Basiliximab View page
Bepotastine View page
Brinzolamide View page
Brompheniramine View page
Chloroxylenol View page
Chromium View page
Dihydroergotamine View page
Diltiazem View page
Dostarlimab View page
Efinaconazole View page
Eliglustat View page
Entrectinib View page
Eptinezumab View page
Erenumab View page
Evinacumab View page
Flunarizine View page
Flurazepam View page
Gadoteridol View page
Idarucizumab View page
Inosine Pranobex View page
Interferon Beta-1A View page
Lemborexant View page
Lodoxamide View page
Mirvetuximab Soravtansine View page
Neratinib View page
Norethindrone Enanthate View page
Nusinersen View page
Obinutuzumab View page
Olaparib View page
Olodaterol View page
Ozanimod View page
Pilocarpine View page
Piperonyl Butoxide View page
Rabeprazole View page
Riociguat View page
Ripretinib View page
Selexipag View page
Sumatriptan View page
Tafamidis View page
Tazobactam View page
Temazepam View page
Teriflunomide View page
Trastuzumab Emtansine View page
Triazolam View page
Yellow Fever Vaccine View page

This site uses Just the Docs, a documentation theme for Jekyll.